Neurotrophic factors in Alzheimer's disease:: role of axonal transport

被引:272
作者
Schindowski, K. [1 ,2 ]
Belarbi, K. [1 ,2 ]
Buee, L. [1 ,2 ]
机构
[1] INSERM, U837, F-59045 Lille, France
[2] Univ Lille 2, Inst Med Predict & Rech Therapeut, Lille, France
关键词
Abeta; APP; BDNF; cholinergic neurons; dementia; neurodegeneration; NGF; NT-3; NT-4/; 5; Tau;
D O I
10.1111/j.1601-183X.2007.00378.x
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Neurotrophic factors (NTF) are small, versatile proteins that maintain survival and function to specific neuronal populations. In general, the axonal transport of NTF is important as not all of them are synthesized at the site of its action. Nerve growth factor (NGF), for instance, is produced in the neocortex and the hippocampus and then retrogradely transported to the cholinergic neurons of the basal forebrain. Neurodegenerative dementias like Alzheimer's disease (AD) are linked to deficits in axonal transport. Furthermore, they are also associated with imbalanced distribution and dysregulation of NTF. In particular, brain-derived neurotrophic factor (BDNF) plays a crucial role in cognition, learning and memory formation by modulating synaptic plasticity and is, therefore, a critical molecule in dementia and neurodegenerative diseases. Here, we review the changes of NTF expression and distribution (NGF, BDNF, neurotrophin-3, neurotrophin-4/5 and fibroblast growth factor-2) and their receptors [tropomyosin-related kinase (Trk)A, TrkB, TrkC and p75(NTR)] in AD and AD models. In addition, we focus on the interaction with neuropathological hallmarks Tau/neurofibrillary tangle and amyloid-beta (Abeta)/amyloid plaque pathology and their influence on axonal transport processes in order to unify AD-specific cholinergic degeneration and Tau and Abeta misfolding through NTF pathophysiology.
引用
收藏
页码:43 / 56
页数:14
相关论文
共 201 条
[131]   Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease [J].
Nacmias, B ;
Piccini, C ;
Bagnoli, S ;
Tedde, A ;
Cellini, E ;
Bracco, L ;
Sorbi, S .
NEUROSCIENCE LETTERS, 2004, 367 (03) :379-383
[132]   Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease [J].
NarisawaSaito, M ;
Wakabayashi, K ;
Tsuji, S ;
Takahashi, H ;
Nawa, H .
NEUROREPORT, 1996, 7 (18) :2925-2928
[133]   Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy [J].
Nishimura, M ;
Kuno, S ;
Kaji, R ;
Kawakami, H .
MOVEMENT DISORDERS, 2005, 20 (08) :1031-1033
[134]   Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells [J].
Nuydens, R ;
Dispersyn, G ;
deJong, M ;
VandenKieboom, G ;
Borgers, M ;
Geerts, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (03) :687-691
[135]   Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism [J].
Olin, D ;
MacMurray, J ;
Comings, DE .
NEUROSCIENCE LETTERS, 2005, 381 (03) :275-278
[136]   β-Amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells:: Influence of the antioxidant melatonin [J].
Olivieri, G ;
Otten, U ;
Meier, F ;
Baysang, G ;
Dimitriades-Schmutz, B ;
Müller-Spahn, F ;
Savaskan, E .
NEUROSCIENCE, 2003, 120 (03) :659-665
[137]   The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion [J].
Olivieri, G ;
Novakovic, M ;
Savaskan, E ;
Meier, F ;
Baysang, G ;
Brockhaus, M ;
Müller-Spahn, F .
NEUROSCIENCE, 2002, 113 (04) :849-855
[138]  
Origlia N, 2006, J ALZHEIMERS DIS, V9, P59
[139]   Trk receptors: mediators of neurotrophin action [J].
Patapoutian, A ;
Reichardt, LF .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :272-280
[140]   Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease [J].
Peng, SY ;
Wuu, J ;
Mufson, EJ ;
Fahnestock, M .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (06) :1412-1421